CELLEXCEL LTD

13550753
Active Norwich

Other research and experimental development on natural sciences and engineering

2 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
C

CELLEXCEL LTD

13550753

Other research and experimental development on natural sciences and engineering

Founded 5 Aug 2021 Active Norwich, United Kingdom 2 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 25 Feb 2026 Next due 31 May 2026 20 days overdue
Confirmation
Net assets £131K £80K 2025 year on year
Total assets £215K £65K 2025 year on year
Total Liabilities £84K £14K 2025 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

The Enterprise Centre University Of East Anglia Norwich Research Park Norwich Norfolk NR4 7TJ United Kingdom

Website

www.example.com

Full company profile for CELLEXCEL LTD (13550753), an active life sciences and medical technology company based in Norwich, United Kingdom. Incorporated 5 Aug 2021. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Sept → 31 Aug 2025
Type total-exemption-full
Next accounts 31 Aug 2025
Due by 31 May 2026 1 month overdue

Net Assets, Total Assets & Total Liabilities (2022–2025)

Cash in Bank

£134.86k

Increased by £45.45k (+51%)

Net Assets

£131.16k

Increased by £79.55k (+154%)

Total Liabilities

£83.90k

Decreased by £14.25k (-15%)

Turnover

N/A

Employees

2

Debt Ratio

39%

Decreased by 27 (-41%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Aug Year End
2024
31 Aug Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 2
Grants 1

Investors (5)

Investor NameInvestor SinceParticipating Rounds
Investor 3Nov 2023Seed
Investor 1Mar 2024Seed
Investor 2Mar 2024Seed

Share Capital

Share Capital

Share allotments and capital structure

7 Allotments 5,267 Shares £1.18m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Apr 20261,421£250k£175.86
13 Oct 20251,589£279k£175.86
13 Oct 202523£0.023£0.001
8 May 20251,421£250k£175.86
22 Dec 2023236£203k£862.07

Officers

Officers

1 active 2 resigned
Status
Timothy Denzil PryceDirectorBritishEngland6015 Aug 2022Active

Shareholders

Shareholders (13)

George Richard Stephenson
19.7%
3,850
Uea Enterprises Ltd
18.7%
3,650

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

George Richard Stephenson

British,australian

Active
Notified 9 Aug 2024
Residence England
DOB April 1953
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Uea Enterprises Ltd

United Kingdom

Active
Notified 9 Aug 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

George Richard Stephenson

Ceased 9 Aug 2024

Ceased

Uea Enterprises Ltd

Ceased 9 Aug 2024

Ceased

Group Structure

Group Structure

CELLEXCEL LTD Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
29 Apr 2026CapitalAllotment of shares (GBP 22.591) on 20 Apr 2026
14 Mar 2026ResolutionResolutions
25 Feb 2026AccountsAnnual accounts made up to 31 Aug 2025
26 Nov 2025OfficersAppointment of Mr Mark Christopher Mitchell as director on 1 Nov 2025
25 Nov 2025OfficersAppointment of Mr Robert James Gunn as director on 1 Nov 2025
29 Apr 2026 Capital

Allotment of shares (GBP 22.591) on 20 Apr 2026

14 Mar 2026 Resolution

Resolutions

25 Feb 2026 Accounts

Annual accounts made up to 31 Aug 2025

26 Nov 2025 Officers

Appointment of Mr Mark Christopher Mitchell as director on 1 Nov 2025

25 Nov 2025 Officers

Appointment of Mr Robert James Gunn as director on 1 Nov 2025

Recent Activity

Latest Activity

Allotment of shares (GBP 22.591) on 20 Apr 2026

1 months ago on 29 Apr 2026

Resolutions

3 months ago on 14 Mar 2026

Annual accounts made up to 31 Aug 2025

3 months ago on 25 Feb 2026

Appointment of Mr Mark Christopher Mitchell as director on 1 Nov 2025

6 months ago on 26 Nov 2025

Appointment of Mr Robert James Gunn as director on 1 Nov 2025

6 months ago on 25 Nov 2025